Major mental health disorders are some of the most difficult conditions to manage. According to a retrospective analysis in Systematic Reviews, almost 450 million people are affected by mental health disorders worldwide, contributing 14% of…
Read more
As the days tick down to the inauguration of President-elect Joseph Biden and Vice President-elect Kamala Harris, what will be the priorities of the new administration when it comes to U.S. healthcare? Let’s take a…
Read more
AllazoHealth CEO Clifford Jones and Chief Operating Officer William Grambley recently answered questions about patient intervention data: what it is, how clients employ it, and how AllazoHealth uses this data to accurately predict individual patient…
Read more
Medication non-adherence continues to be one of the most widespread issues faced by the pharmaceutical industry. According to the U.S. Centers for Disease Control, approximately 50 percent of people with chronic illnesses stop taking their…
Read more
There are a lot of companies that claim they offer solutions that are powered by artificial intelligence (AI) and/or machine learning. But what exactly does that mean? AI and machine learning Artificial intelligence is a…
Read more
For payers and pharmacists, designing an effective adherence program to support patients can be challenging, according to AllazoHealth’s William Grambley, COO, and Dr. Linda Schultz, VP, Clinical and Customer Success. Keeping these tips in mind…
Read more
Barriers to medication adherence can take the form of social determinants such as housing, employment and access to pharmacies – and systemic barriers such as pre-approvals, multiple prescriptions and affordability. But psychological barriers also play…
Read more
Payers, pharmacies and pharmaceutical companies are starting to join providers in recognizing that social determinants of health (SDOH) have a major impact on patient adherence and clinical outcomes. Healthcare organizations now face the challenge of…
Read more